Email updates

Keep up to date with the latest news and content from BMC Cancer and BioMed Central.

Open Access Pre-publication history

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131

Yun Choi, Ho Won Lee, Jaetae Lee and Yong Hyun Jeon*

BMC Cancer 2013, 13:143  doi:10.1186/1471-2407-13-143

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 13 Jul 2012
Resubmission - Version 2 Manuscript 16 Jul 2012
Reviewer's Report Dongmei He 08 Aug 2012
Reviewer's Report Catherine Brenner 09 Nov 2012
Resubmission - Version 3 Manuscript Author's comment 03 Dec 2012
Reviewer's Report Dongmei He 07 Dec 2012
Resubmission - Version 4 Manuscript Author's comment 02 Jan 2013
Resubmission - Version 5 Manuscript Author's comment 02 Jan 2013
Reviewer's Report Dongmei He 06 Jan 2013
Resubmission - Version 6 Manuscript Author's comment 15 Jan 2013
Editorial acceptance 30 Jan 2013
Published 22 Mar 2013